In this episode, our editor-in-chief Taissa Vila sits down with Dr. Beatriz Grinsztejn to discuss the challenges of expanding access to pre-exposure prophylaxis (PrEP), with a focus on issues of adherence and equity in Latin America. 

We explore the potential of Lenacapavir as a game-changing intervention, reflect on lessons learned from previous experiences with injectable PrEP, and examine the critical importance of introducing new prevention tools through an equity-based approach. 

Finally, we look ahead to what Lenacapavir could mean for the future of HIV prevention strategies worldwide. Tune in for an insightful conversation on how innovative strategies like Lenacapavir could reshape the future of HIV awareness and prevention.

In this episode, join our editorial team for a lively roundtable as we introduce our new Lancet Regional Health Americas podcast channel and reflect on the first half of 2025. We share our favourite published articles of the year, discuss our vision for advancing clinical practice, health policy, and research across the Americas, and explore key health trends to watch in the coming months.